Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$13.42 - $25.18 $732,732 - $1.37 Million
-54,600 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$19.28 - $24.59 $98,154 - $125,187
-5,091 Reduced 8.53%
54,600 $1.22 Million
Q4 2020

Feb 02, 2021

SELL
$15.1 - $26.44 $18,120 - $31,728
-1,200 Reduced 1.97%
59,691 $1.33 Million
Q3 2020

Nov 05, 2020

BUY
$13.39 - $17.48 $17,407 - $22,724
1,300 Added 2.18%
60,891 $899,000
Q2 2020

Aug 12, 2020

BUY
$8.94 - $20.98 $404,007 - $948,107
45,191 Added 313.83%
59,591 $883,000
Q4 2019

Jan 27, 2020

BUY
$5.43 - $9.22 $78,192 - $132,768
14,400 New
14,400 $126,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $792M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.